JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
Northwest Bancshares
NWBI
$2.19B
| $3.85M | ﹤0.01% |
320,157
+179,925
| +128% | +$2.44M |
2015 Q4
29 quarters
|
|
|
VGR
2902
DELISTED
Vector Group Ltd.
VGR
| $3.85M | ﹤0.01% |
320,637
+72,894
| +29% | +$919K |
2015 Q4
29 quarters
|
|
2903
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16B
| $3.85M | ﹤0.01% |
101,816
-82,039
| -45% | -$3.2M |
2021 Q2
7 quarters
|
|
2904
Ubiquiti
UI
$37.9B
| $3.84M | ﹤0.01% |
14,128
+742
| +6% | +$205K |
2013 Q2
39 quarters
|
|
|
EFC
2905
Ellington Financial
EFC
$1.5B
| $3.82M | ﹤0.01% |
312,790
+26,447
| +9% | +$341K |
2018 Q4
17 quarters
|
|
2906
BOK Financial
BOKF
$7.79B
| $3.81M | ﹤0.01% |
45,142
-3,495
| -7% | -$342K |
2019 Q2
15 quarters
|
|
|
CVSA
2907
Covista Inc
CVSA
$4.31B
| $3.81M | ﹤0.01% |
98,593
+28,018
| +40% | +$1.07M |
2013 Q2
39 quarters
|
|
2908
CALL
BP
BP
$116B
| $3.79M | ﹤0.01% |
100,000
+11,000
| +12% | +$411K |
2021 Q4
5 quarters
|
|
2909
CALL
Biogen
BIIB
$32.9B
| $3.78M | ﹤0.01% |
13,600
-92,700
| -87% | -$25.6M |
2021 Q3
6 quarters
|
|
2910
Global X FinTech ETF
FINX
$158M
| $3.78M | ﹤0.01% |
181,375
-22,883
| -11% | -$480K |
2019 Q2
15 quarters
|
|
|
CPE
2911
DELISTED
Callon Petroleum Company
CPE
| $3.78M | ﹤0.01% |
112,909
+39,486
| +54% | +$1.49M |
2015 Q1
32 quarters
|
|
|
ARI
2912
Apollo Commercial Real Estate
ARI
$803M
| $3.77M | ﹤0.01% |
405,423
+200,748
| +98% | +$2.22M |
2013 Q2
39 quarters
|
|
|
NXH
2913
Neighborhood Intelligence Inc
NXH
$175M
| $3.76M | ﹤0.01% |
204,150
+25,356
| +14% | +$473K |
2017 Q4
21 quarters
|
|
|
OZON
2914
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $3.74M | ﹤0.01% |
322,613
+200
| +0.1% | +$2.32K |
2021 Q1
8 quarters
|
|
|
ENFN
2915
DELISTED
Enfusion, Inc.
ENFN
| $3.74M | ﹤0.01% |
355,909
+333,982
| +1,523% | +$3.68M |
2021 Q4
5 quarters
|
|
2916
Genesco
GCO
$391M
| $3.73M | ﹤0.01% |
101,108
-3,017
| -3% | -$132K |
2013 Q2
39 quarters
|
|
2917
Perdoceo Education
PRDO
$2.01B
| $3.73M | ﹤0.01% |
277,789
-54,329
| -16% | -$761K |
2015 Q4
29 quarters
|
|
2918
Under Armour
UAA
$2.1B
| $3.72M | ﹤0.01% |
392,504
+49,816
| +15% | +$518K |
2013 Q2
39 quarters
|
|
2919
Upland Software
UPLD
$11.1M
| $3.72M | ﹤0.01% |
86,591
+11,183
| +15% | +$775K |
2017 Q2
23 quarters
|
|
|
IMGN
2920
DELISTED
Immunogen Inc
IMGN
| $3.72M | ﹤0.01% |
968,733
+752,266
| +348% | +$3.21M |
2016 Q4
25 quarters
|
|
|
FORG
2921
DELISTED
ForgeRock, Inc.
FORG
| $3.72M | ﹤0.01% |
180,493
-88,673
| -33% | -$1.8M |
2022 Q2
3 quarters
|
|
2922
Cerence
CRNC
$365M
| $3.71M | ﹤0.01% |
131,904
+9,153
| +7% | +$235K |
2019 Q4
13 quarters
|
|
2923
CoreCivic
CXW
$3.14B
| $3.7M | ﹤0.01% |
402,389
+13,270
| +3% | +$136K |
2013 Q2
39 quarters
|
|
2924
CTS Corp
CTS
$1.74B
| $3.7M | ﹤0.01% |
74,822
+15,579
| +26% | +$697K |
2016 Q2
27 quarters
|
|
2925
PUT
Snap
SNAP
$9.78B
| $3.69M | ﹤0.01% |
329,500
-2,820,300
| -90% | -$29.6M |
2020 Q3
10 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.